We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.
- Authors
Hirsch, Martin S; Brun-Vézinet, Françoise; Clotet, Bonaventura; Conway, Brian; Kuritzkes, Daniel R; D'Aquila, Richard T; Demeter, Lisa M; Hammer, Scott M; Johnson, Victoria A; Loveday, Clive; Mellors, John W; Jacobsen, Donna M; Richman, Douglas D
- Abstract
New information about the benefits and limitations of testing for resistance to human immunodeficiency virus (HIV) type 1 (HIV-1) drugs has emerged. The International AIDS Society-USA convened a panel of physicians and scientists with expertise in antiretroviral drug management, HIV-1 drug resistance, and patient care to provide updated recommendations for HIV-1 resistance testing. Published data and presentations at scientific conferences, as well as strength of the evidence, were considered. Properly used resistance testing can improve virological outcome among HIV-infected individuals. Resistance testing is recommended in cases of acute or recent HIV infection, for certain patients who have been infected as long as 2 years or more prior to initiating therapy, in cases of antiretroviral failure, and during pregnancy. Limitations of resistance testing remain, and more study is needed to refine optimal use and interpretation.
- Publication
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Vol 37, Issue 1, p113
- ISSN
1537-6591
- Publication type
Journal Article
- DOI
10.1086/375597